Adult Primary and Preventive Practice (APPP) Study

Preventive Care Clinical Trial

— APPP  

Official title:

Adult Primary and Preventive Practice (APPP) Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02915653
• Other study ID #: Pro000018813
• Status: Completed
• Phase: N/A
• Start date: September 2016
• Est. completion date: November 2017

Study information

• Verified date: June 2018
• Source: Qure Healthcare, LLC
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study is a pre-post two round, randomized controlled study design of PCPs randomly assigned to a control or 1 of 2 intervention arms.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 213
• Est. completion date: November 2017
• Est. primary completion date: November 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 1. Provide consent to participate in the study 2. Board-certified physician currently practicing in the following areas: 3. Internal medicine 4. Family medicine 5. Have practiced as a board-certified physician in internal or family medicine for greater than 2 but less than 30 years. 6. English-speaking 7. Community / non-academic based practice setting 8. = 40 patients under care weekly 9. Access to the internet

Exclusion Criteria:

• 1. Not board certified in their respective area of care 2. Academic-based practice 3. Have practiced as a board-certified physician for less than 2 or greater than 30 years

4. Follow <40 patients weekly 5. Non-English speaking 6. Unable to access the internet

Related Conditions & MeSH terms

• Preventive Care

Intervention

Other:
• Educational materials on a new diagnostic service
Educational materials on a new diagnostic service

Locations

Country	Name	City	State
United States	QURE Healthcare	San Francisco	California

Sponsors (2)

Lead Sponsor	Collaborator
Qure Healthcare, LLC	Applied Proteomics Inc

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of Care	Difference in difference of combined diagnostic and treatment CPV domain scores, including colonoscopy referral rates, in post-intervention versus baseline comparing intervention and control groups among the three patient types.	8 weeks
Secondary	Intervention Impact on Care	Difference in difference between the control and intervention groups in the overall quality of care for CRC screening and for adult primary prevention care measured by the combined and individual item CPV scores for the three patient types.	8 weeks
Secondary	Healthcare Utilization	Difference in health care utilization and/or costs in patients tested with SimpliPro Colon™ versus the control group.	8 weeks
Secondary	Diagnostic Method Comparison	Difference in recommendation of CRC evaluation with colonoscopy and/or flexible sigmoidoscopy, double barium enema, or CT colonography, including risk-level and urgency pre- and post-intervention, between intervention and control groups	8 weeks